These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1655110)

  • 21. A new model of temporary focal neocortical ischemia in the rat.
    Buchan AM; Xue D; Slivka A
    Stroke; 1992 Feb; 23(2):273-9. PubMed ID: 1561658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
    Umemura K; Shimakura A; Nakashima M
    Brain Res; 1997 Oct; 773(1-2):61-5. PubMed ID: 9409705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental stroke and neuroprotection in the aging rat brain.
    Davis M; Mendelow AD; Perry RH; Chambers IR; James OF
    Stroke; 1995 Jun; 26(6):1072-8. PubMed ID: 7762026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury.
    Du C; Hu R; Hsu CY; Choi DW
    J Neurotrauma; 1996 Apr; 13(4):215-22. PubMed ID: 8860202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
    Lo EH; Pierce AR; Mandeville JB; Rosen BR
    Stroke; 1997 Feb; 28(2):439-46; discussion 446-7. PubMed ID: 9040703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
    Nakai A; Kuroda S; Kristián T; Siesjö BK
    Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension and hyperglycemia in experimental stroke.
    Slivka AP
    Brain Res; 1991 Oct; 562(1):66-70. PubMed ID: 1799873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
    Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
    Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual effects of L-NAME during transient focal cerebral ischemia in spontaneously hypertensive rats.
    Ashwal S; Cole DJ; Osborne TN; Pearce WJ
    Am J Physiol; 1994 Jul; 267(1 Pt 2):H276-84. PubMed ID: 8048592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model.
    Meden P; Overgaard K; Sereghy T; Boysen G
    J Neurol Sci; 1993 Nov; 119(2):209-16. PubMed ID: 8277337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.
    Yatsugi S; Takahashi M; Kawasaki-Yatsugi S; Koshiya K; Sakamoto S; Uematsu D; Shimizu-Sasamata M
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):959-66. PubMed ID: 8784240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema.
    Westergren I; Johansson BB
    Brain Res; 1992 Feb; 573(2):324-6. PubMed ID: 1354550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor blockade on increased cerebral O(2) consumption in Eker rats.
    Weiss HR; Liu X; Hunter C; Chi OZ
    Brain Res; 2009 Oct; 1294():138-43. PubMed ID: 19686708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats.
    Shimizu-Sasamata M; Kano T; Rogowska J; Wolf GL; Moskowitz MA; Lo EH
    Stroke; 1998 Oct; 29(10):2141-8. PubMed ID: 9756596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil.
    Judge ME; Sheardown MJ; Jacobsen P; Honoré T
    Neurosci Lett; 1991 Dec; 133(2):291-4. PubMed ID: 1667818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitation of postischemic reperfusion with alpha-PBN: assessment using NMR and Doppler flow techniques.
    Schulz JB; Panahian N; Chen YI; Beal MF; Moskowitz MA; Rosen BR; Jenkins BG
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1986-95. PubMed ID: 9139987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model.
    Kittaka M; Giannotta SL; Zelman V; Correale JD; DeGiorgio CM; Weiss MH; Zlokovic BV
    J Neurosurg; 1997 Nov; 87(5):731-7. PubMed ID: 9347982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postischemic brain injury is affected stereospecifically by pentazocine in rats.
    Takahashi H; Traystman RJ; Hashimoto K; London ED; Kirsch JR
    Anesth Analg; 1997 Aug; 85(2):353-7. PubMed ID: 9249113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia.
    DeGraba TJ; Ostrow P; Hanson S; Grotta JC
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):262-8. PubMed ID: 8113322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.